{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:52:15Z","timestamp":1790149935650,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.brainresbull.2010.01.009","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T05:02:20Z","timestamp":1264482140000},"page":"543-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat"],"prefix":"10.1016","volume":"81","author":[{"given":"Sin\u00e9ad","family":"Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Mnich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne M.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eil\u00eds","family":"Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2010.01.009_bib1","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1353-8020(98)00013-3","article-title":"The effect of l-3,4-dihydroxyphenylalanine (=DOPA) on akinesia in Parkinsonism","volume":"4","author":"Birkmayer","year":"1998","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.0254","article-title":"Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function","volume":"256","author":"Bisogno","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1471-4892(02)00011-5","article-title":"CB1 cannabinoid receptor signalling in Parkinson's disease","volume":"3","author":"Brotchie","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","article-title":"Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging","volume":"15","author":"Cicchetti","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM196902132800701","article-title":"Modification of Parkinsonism\u2014chronic treatment with l-dopa","volume":"280","author":"Cotzias","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0091-3057(93)90230-Q","article-title":"Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents","volume":"46","author":"Crawley","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib8","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1111\/j.1460-9568.2003.03014.x","article-title":"Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease","volume":"18","author":"Depino","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib10","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1096\/fasebj.14.10.1432","article-title":"Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease","volume":"14","author":"Di Marzo","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbr.2004.10.010","article-title":"Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in a lateralised nose-poking task in rats","volume":"159","author":"Dowd","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbr.2005.06.036","article-title":"Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in rats using a lateralised nose-poking task with low stimulus-response compatibility","volume":"165","author":"Dowd","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainresbull.2005.08.009","article-title":"The Corridor Task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum","volume":"68","author":"Dowd","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1","article-title":"Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB","volume":"422","author":"Egertova","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib15","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"[Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system.]","volume":"38","author":"Ehringer","year":"1960","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1749-6632.1992.tb24519.x","article-title":"Neuropathologic features of Parkinson's, Huntington's, and Alzheimer's diseases","volume":"648","author":"Forno","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties","volume":"1134","author":"Garcia-Arencibia","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/7268","article-title":"Dopamine activation of endogenous cannabinoid signaling in dorsal striatum","volume":"2","author":"Giuffrida","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0306-4522(93)90352-G","article-title":"Loss of cannabinoid receptors in the substantia nigra in Huntington's disease","volume":"56","author":"Glass","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2010.01.009_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2008.08.018","article-title":"Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat","author":"Grealish","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib21","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1523\/JNEUROSCI.22-16-06900.2002","article-title":"Experimental Parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission","volume":"22","author":"Gubellini","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-8993(91)90970-7","article-title":"Neuronal localization of cannabinoid receptors in the basal ganglia of the rat","volume":"547","author":"Herkenham","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib23","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1098-2396(200007)37:1<71::AID-SYN8>3.0.CO;2-K","article-title":"Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study","volume":"37","author":"Hohmann","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.brainresbull.2010.01.009_bib25","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00702-003-0033-7","article-title":"Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain","volume":"110","author":"Hurley","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature05506","article-title":"Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models","volume":"445","author":"Kreitzer","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2010.01.009_bib28","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1046\/j.0953-816x.2001.01812.x","article-title":"Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets","volume":"14","author":"Lastres-Becker","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0306-4522(92)90409-U","article-title":"Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry","volume":"48","author":"Mailleux","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2010.01.009_bib30","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/j.1471-4159.1993.tb09807.x","article-title":"Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study","volume":"61","author":"Mailleux","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/cne.903270406","article-title":"Localization of cannabinoid receptor mRNA in rat brain","volume":"327","author":"Matsuda","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2010.01.009_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuroscience.2005.09.005","article-title":"Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia","volume":"137","author":"Matyas","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2010.01.009_bib34","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2010.01.009_bib35","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0196-9781(00)00324-7","article-title":"Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study","volume":"21","author":"Moldrich","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.brainresbull.2010.01.009_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/(SICI)1097-4547(19980201)51:3<391::AID-JNR12>3.0.CO;2-A","article-title":"Immunohistochemical localization of the neural cannabinoid receptor in rat brain","volume":"51","author":"Pettit","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib37","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ana.20462","article-title":"High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients","volume":"57","author":"Pisani","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib38","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/j.1460-9568.2009.06764.x","article-title":"WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"29","author":"Price","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib39","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ramirez","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0024-3205(99)00618-9","article-title":"Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen","volume":"66","author":"Romero","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib41","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/0024-3205(95)00186-A","article-title":"The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons","volume":"56","author":"Romero","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib42","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0024-3205(99)00293-3","article-title":"Motor actions of cannabinoids in the basal ganglia output nuclei","volume":"65","author":"Sanudo-Pena","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1749-6632.1998.tb09081.x","article-title":"A novel neurotransmitter system involved in the control of motor behavior by the basal ganglia","volume":"860","author":"Sanudo-Pena","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2010.01.009_bib46","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0306-4522(02)00109-4","article-title":"Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse","volume":"113","author":"Wallmichrath","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2010.01.009_bib47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/0269881108088194","article-title":"A study investigating the acute dose-response effects of 13mg and 17mg Delta 9-tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana","volume":"22","author":"Weinstein","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2010.01.009_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3940(99)00762-4","article-title":"Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats","volume":"276","author":"Zeng","year":"1999","journal-title":"Neurosci. Lett."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923010000286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923010000286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:07:27Z","timestamp":1759781247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923010000286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0361923010000286"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2010.01.009","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2010.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}